Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.
about
Role of HIV in amyloid metabolismHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Neuroimaging of HIV-associated neurocognitive disorders (HAND)PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.HIV-associated neurocognitive disorder.Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir.Interactions between ageing and NeuroAIDS.Brain alterations within the first 100 days of HIV infection.HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.HIV eradication symposium: will the brain be left behind?Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targetsLack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging studyNeuroinflammation in treated HIV-positive individuals: A TSPO PET study.(18)F-DPA-714 PET Imaging for Detecting Neuroinflammation in Rats with Chronic Hepatic Encephalopathy.Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.Morphometric characterization of microglial phenotypes in human cerebral cortexBehavioral and neuroimaging evidence for impaired executive function in "cognitively normal" older HIV-infected adults.Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.HIV and the spectrum of human disease.Fate of microglia during HIV-1 infection: From activation to senescence?Cognitive Impairment and Persistent CNS Injury in Treated HIV.Treating HIV Infection in the Central Nervous System.Role of microglia in methamphetamine-induced neurotoxicity.Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.HIV encephalopathy: glial activation and hippocampal neuronal apoptosis, but limited neural repair.Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.[HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition.HIV as a Cause of Immune Activation and Immunosenescence.Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?
P2860
Q26824179-2C9428B2-E9E9-4FA6-8BC0-10CE661F0314Q30234305-64E78CFA-FF11-41DE-8591-847F7713354DQ30854917-FC244367-E67F-4710-B0C5-9D1643A8578CQ31153188-12D659AD-12A2-4D09-B565-E1AF31BCBC20Q33834306-F0DCD56A-619A-4CE5-9F14-52F8C0297790Q33939729-1DA3B669-72D7-4F8F-BAEC-7D61B73482EBQ34485748-CA5223F6-5B99-43EC-BDD7-E8529E884F0FQ34977613-6CCBFFB0-B863-46DA-AF92-BAF99BAB54E5Q34994446-F2504C69-B36C-49BA-BB18-9B1D66066ECFQ35276630-73341ABE-D14A-4CC8-AF9D-49A94D79EF51Q35338414-421FA98F-00AC-4CD5-8768-215324D42AFFQ35607587-9C3C1637-8AAD-4951-B80A-51FBE5122360Q35997428-0F4DC8EE-0691-4856-B488-F2C47D7B2AFEQ36070781-E2037BF2-DAF1-4343-B614-534CC27B8869Q36796466-9CFF9423-4778-4A4C-81F6-C45C54892446Q36970398-DA7F80EA-BACC-42C3-9ACC-CC30EE6DE470Q37340889-801A7F1E-F47F-4779-AB0C-B3FBC34E2871Q37532369-7F28535F-99BF-4070-8AA7-65C21AD0D910Q37693236-F9DE4F29-10FE-445E-ABBD-7625B9EAC836Q38210096-1E1FB465-BBD0-4AF0-8E02-2A87C4A2CAD0Q38217388-22628424-C074-4A81-B04D-53BAACE4E646Q38247035-15FD5618-EF11-4D31-9331-1FC9E0DE9931Q38253928-753C0FC9-1AC8-4724-A80A-BDBE22A32A0EQ38790617-FA4177A8-5F12-477D-BCFE-A17AF06275AFQ38836472-D50917AD-CE39-4756-844D-8A7011BC6B75Q39077816-BB2DA7B6-1CF8-414B-8219-689A1BF3DAFCQ39427179-7562A7FA-A2BA-4F14-AA8F-B59E4078EC25Q39598073-F63BECCE-80B4-4BA7-91AB-C1834CA9F87CQ40182580-1A92BD95-B296-4421-BE41-C9FBFE9385E1Q40437527-743B8D7A-2A77-4D24-893F-BB50CD9FDEE8Q40458885-9582EB66-BDEE-43DD-A596-89980627E744Q40932221-CB43D794-9E44-4BD1-B198-C7A914ED21C7Q41107466-16DF5842-8D11-4CC7-ACDF-1080FAB66053Q41466517-66C215AD-8D7F-46BE-BCC9-AFCC8CCD40DCQ41712400-A82A281E-E9C7-42D2-AB09-987E024F9C77Q41991842-99EA0548-65EF-476E-A286-5BDAB596185BQ42203691-CD5205EA-25AF-4E65-9D06-BC710DE90CE5Q42725641-2AEF34C3-8149-4C83-8F09-8A4A92156A51Q47151081-A49D5117-1BCC-4126-80E1-A938443D31B3Q50200827-968D8455-A46F-473E-987A-448083FED09F
P2860
Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Increased microglia activation ...... ients receiving effective ART.
@en
Increased microglia activation ...... ients receiving effective ART.
@nl
type
label
Increased microglia activation ...... ients receiving effective ART.
@en
Increased microglia activation ...... ients receiving effective ART.
@nl
prefLabel
Increased microglia activation ...... ients receiving effective ART.
@en
Increased microglia activation ...... ients receiving effective ART.
@nl
P2093
P921
P1433
P1476
Increased microglia activation ...... tients receiving effective ART
@en
P2093
Alan Winston
Anil Ramlackhansingh
Lucy J Garvey
Marios Politis
Simon D Taylor-Robinson
P356
10.1097/01.AIDS.0000432467.54003.F7
P407
P577
2014-01-01T00:00:00Z